Neurologische Manifestationen bei COVID-19. S2k-LL (DGN)
- MeSH Terms
- Guideline Contact
- Ina Kopp (imwi@awmf.org)
- English Title Translation
- Neurological manifestations in COVID-19
- Keywords
- SARS-CoV-2, COVID-19, Long-COVID-Symptomatik, Post-COVID-Symptomatik, SARS-CoV-2-Impfung, Anosmie, Hyposmie, Parosmie, Phantosmie, Ageusie, Hypogeusie, Epidemiologie, Enzephalopathie, Zytokinsturm, Enzephalitis, epileptische Anfälle, Anfallsrezidiv, Arzneimittelinteraktionen, Fatigue, Kognition, Meningoenzephalitis, Myelitis, Enzephalomyelitis, neuromuskuläre Erkrankungen, Myositis, Myasthenia gravis, Guillain-Barré-Syndrom, MillerFisher-Syndrom, critical illness weakness, critical illness neuropathy, critical illness myopathy, Intensive Care Unit-acquired weakness, ECMO, Beatmung, Aufwachreaktion, Delir, Status epilepticus, Neuromonitoring, Schlaganfall, intrazerebrale Blutung, intrakranielle Blutung, Vakzin-induzierte immunogene thrombotische Thrombozytopenie (VITT), Sinus- und Hirnvenenthrombose, Fatigue, ME/CFS
- Date for Review
- 14/01/2029
- Publication Date
- 14/02/2024
- Publication Scope
- management
- Countries of Application
- Germany
- Guideline Publication Status
- Published
- Languages
- German
- Authors
- AWMF (DE)
- Publication Year
- 2024